crowdreviews.com

Strategic Partner

October 30, 2017 - November 1, 2017

3rd Annual Congress on Rare Diseases and Orphan Drugs

San Antonio, Texas

Map Event Location Share this Event

Event Details

Begins: October 30, 2017

End: November 1, 2017

Event Location: San Antonio, Texas

Website: http://raredisease..eries.com

Event Organizer

Event Organizer: Conference Series

Contact Person: Natalia Jones

Phone Number: (702) 508-5200 Ext: 8049

Website: https://www.conferenceseries.com/

Overview

After the overwhelming success of the previous conference in 2016, Rare Diseases-2017 scientific committee officially announcing “3rd Annual Congress on Rare Diseases and Orphan Drugs” in collaboration with Organization for Rare Diseases India (ORDI) along with Editorial Board Members, External Scientific Association, Researchers, Academicians, and Pharmaceutical Market Leaders around the globe, scheduled on October 30-November 1, 2017 San Antonio, USA.

The aim of this conference is to learn and share knowledge on current research, leading worldwide researchers, scientists, academic scientists, industry researchers, scholars, decision makers and other professionals to gather in San Antonio to speak on rare diseases and orphan drugs.

The main theme of the conference is “Platform to share new treatments and research for Rare Diseases”.

Rare Diseases 2017 encourages sessions on the topics: Different types of Rare Diseases, Clinical Research and Public Awareness, Challenges in Rare Diseases Treatment, Rare Diseases in Cancer, Orphan Drugs- development trends and strategies, Clinical Research on Orphan Drugs, Orphan Drugs and Ethical Issues and many more.

For more details please visit http://rarediseases.conferenceseries.com/

For further queries, please contact:
Natalia Jones
Program Manger| Rare Diseases-2017
Conference Series LLC
Office: (702) 508-5200 Ext: 8049
Email: [email protected]

BECOME A STRATEGIC PARTNER

We are looking to build strategic relationships with conference and event organizers paving the way for industry advancements and education.